Nutritional Status of Patients After Hematopoietic Stem Cell Transplantation

April 16, 2024 updated by: Sheng-Li Xue, MD, The First Affiliated Hospital of Soochow University

A Survey of Nutritional Status of Patients After Hematopoietic Stem Cell Transplantation

The main objectives of this study were :(1) to comprehensively and systematically evaluate the nutritional status of patients after hematopoietic stem cell transplantation. (2) to explore the effect of nutritional factors on the prognosis of patients treated by hematopoietic stem cell transplantation.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

This study is devised to investigate nutritional status in patients who have undergone hematopoietic stem cell transplantation in the First Affiliated Hospital of Soochow University. Evaluation time points include the day before receiving conditioning regimen, post-transplantation 180 days, the nutritional status of patients were systematically evaluated from the aspects of food intake, physical activity level, body composition, blood biochemistry, etc. Also, the effect of nutritional factors on prognosis of hematopoietic stem cell transplantaion patients will be evaluated.

Study Type

Observational

Enrollment (Estimated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Jiangsu
      • Suzhou, Jiangsu, China, 215000
        • Recruiting
        • The First Affiliated Hospital of Suzhou University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 80 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients who have received hematopoietic stem cell transplantation in the First Affiliated Hospital of Soochow University

Description

Inclusion Criteria:

  • Patients who undergo hematopoietic stem cell transplantation in the First Affiliated Hospital of Soochow University.
  • Having a life expectancy of more than 3 months

Exclusion Criteria:

  • Not willing to participate in the investigation
  • Age less than 15 years old or more than 80 years old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline fat free mass at 6 months
Time Frame: 6 months
Body composition analyzer INBO DY S10 (bioelectrical impedance method) is used to analyze the content of fat free mass( kilograms)
6 months
Change from Baseline fat mass at 6 months
Time Frame: 6 months
Body composition analyzer INBODY S10 (bioelectrical impedance method) is used to analyze the content of fat mass( kilograms)
6 months
Change from Baseline food intake at 6 months
Time Frame: 6 months
24-hour dietary record and semi-quantitative food frequency questionnaire are used to evaluate the eating condition of patients
6 months
Change from Baseline albumin level in blood at 6 months
Time Frame: 6 months
The content of albumin in blood is determined.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall survial
Time Frame: 3 years
It is measured from the date of entry into this trial to the date of death from any cause; patients not known to have died at last follow-up are censored on the date they were last known to be alive
3 years
Event free survival
Time Frame: 3 years
It is measured from the date of entry into this trial to the date of relapse from CR, or CRi, or death from any cause; patients not known to have any of these events are censored on the date they were last examined.
3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2018

Primary Completion (Estimated)

December 30, 2024

Study Completion (Estimated)

December 30, 2024

Study Registration Dates

First Submitted

October 14, 2019

First Submitted That Met QC Criteria

October 30, 2019

First Posted (Actual)

October 31, 2019

Study Record Updates

Last Update Posted (Actual)

April 17, 2024

Last Update Submitted That Met QC Criteria

April 16, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • SZnutri01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hematopoietic Stem Cell Transplantation

Clinical Trials on not have

3
Subscribe